Stay updated on Galidesivir Safety/PK/Antiviral Effects in Yellow Fever/COVID-19 Clinical Trial
Sign up to get notified when there's something new on the Galidesivir Safety/PK/Antiviral Effects in Yellow Fever/COVID-19 Clinical Trial page.
Latest updates to the Galidesivir Safety/PK/Antiviral Effects in Yellow Fever/COVID-19 Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.1%
- Check19 days agoChange DetectedThe website has updated the contact details section for the study, now providing information on who to contact for questions about joining the study and where it is taking place, while removing the previous wording about those conducting the study.SummaryDifference3%
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedSeveral links to clinical trial resources and disease information have been removed, including those related to stomach cancer and specific drug searches, which may impact access to important medical data.SummaryDifference4%
- Check40 days agoChange DetectedNew resources have been added, including links to rare disease information, drug information for Lenvatinib and Pembrolizumab, and various government health websites.SummaryDifference0.4%
- Check48 days agoChange DetectedThe website has been updated to version v2.12.2, adding new features for downloading data in various formats and providing detailed participant and study information, while the previous version v2.12.1 has been removed.SummaryDifference4%
- Check55 days agoChange DetectedThe website has been updated from version 2.12.0 to 2.12.1.SummaryDifference0.1%
Stay in the know with updates to Galidesivir Safety/PK/Antiviral Effects in Yellow Fever/COVID-19 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Galidesivir Safety/PK/Antiviral Effects in Yellow Fever/COVID-19 Clinical Trial page.